Human and rat placental homogenates convert L-thyroxine (T4) to 3,5,3'-L-triiodothyronine (T3) 
Introduction
Human and rat placenta have an iodothyronine 5'-deiodinating pathway that is thiol dependent, largely localized to particulate subcellular fractions, and insensitive to inhibition by 6-n-propylthiouracil (PTU)' (1, 2) . It has an apparent Michaelis constant (Ki) for L-thyroxine (T4) of 2-3 nM, and T4 is a better substrate than 3,3',5'-L-triiodothyronine (rT3), as judged by a higher ratio of apparent maximum reaction velocity (Vmax) to Km for T4. These reaction characteristics correspond to those of a deiodinating pathway identified in rat pituitary, central nervous system, and brown adipose tissue (3-7), but not, so far, in other tissues. The potential physiological significance of this pathway, termed type II iodothyronine deiodination, and two other deiodinating pathways in rat tissues has been reviewed (8) . It is yet not known how many separate enzyme molecules are represented by these pathways, and the relationship of the type II pathway to the recently described low Km pathway in rat renal microsomes (9) also remains uncertain.
The increase in type II deiodination induced by hypothyroidism in several rat tissues tested in vitro (3, 5, 6, 8) suggests an adaptive function for this enzyme, whereby intracellular 3,5,3'-L-triiodothyronine (T3) concentrations might be defended in mild-to-moderate hypothyroidism, to a greater extent than predicted from serum T4 and T3 concentrations. There is evidence for the operation of this mechanism in the rat in vivo (10) (11) (12) (13) . Thus far, there is no direct evidence for such an adaptive role for type II deiodination in man. The goals of the present studies were to develop a system to study regulation of iodothyronine deiodination in intact dispersed human placental cells, to verify that intact human placental cells can convert T4 to T3 via the same reaction pathway observed in microsomal preparations, and to ascertain whether the T4 5'-deiodination rate in human placental cells increases in response to thyroid hormone deficiency. We used the outer, chorionic fetal membrane, which has an adherent layer of maternal decidual cells, as the source ofcells, because that membrane has the highest T4 5'-deiodinase activity of the several placental structures tested (1).
Methods
Cell dispersion. Normal human placentas were obtained within 1 h of vaginal or caesarian delivery of healthy, full-term (38-42 wk) infants (preliminary studies have shown that there was no loss in cell viability up to 3 h after delivery). Placentas used for primary cultures were from Caesarian deliveries and were kept sterile.
The amnion was peeled away from the chorionic membrane, to which a layer of decidua adheres, and the latter was washed (6-10 times) with Hanks' balanced salt solution (HBSS) (Gibco Laboratories, Grand Island, NY) until the supernate did not get any clearer, indicating that blood removal was maximized. The chorion-decidual membrane was then minced and submitted to digestion in HBSS with 2 Cells liberated between 30 and 90 min were passed through a 149-gm nylon mesh and collected. Cell viability, assessed by trypan blue exclusion, was 82-94%. The cellular protein content was 250±50 Mg/million cells.
Cell culture. Cell incubations longer than 8 h were carried out under sterile conditions. The cells were maintained in M-199 with 10% calf serum, 1.0% penicillin-streptomycin (Gibco Laboratories), 20 mM Hepes, and 27 mM NaHCO3, pH 7.4, unless otherwise indicated, under an atmosphere of 95% air/5% CO2 at 370C. In experiments with up to 2.0 X 106 cells/well, a multiwell dish (Costar, Cambridge, MA) with 5-cm2 wells were used. When more cells were used, they were plated in a 25-cm2 plastic petri dish (Nunclon-Delta, Roskilde, Denmark). Medium was changed every other day, using 1 ml of medium per 106 cells.
5 were isolated, from media and cell extracts by descending paper chromatography in t-amyl alcohol/hexane/2 N NH40H/5: 1:6 (TAA) (15) or by affinity chromatography on anti-T3 antibody-Sepharose (16), followed by descending paper chromatography in TAA. Affinity chromatography was used (usually for medium samples) when counts in the ['25I]T3 spot were 3.5% or less of the total counts in strips spotted directly; at higher percentages, the results were in excellent agreement with direct paper chromatography, whereas below 3.5%, direct chromatography overestimated the [ (19) . Preliminary experiments using paper chromatographic analysis established that under these conditions, equal amounts of 25.I-and ['"2I]T3
were produced from ['"2IT4. Previous studies showed that product formation was linear with time for 2 h, and that at the proteins concentrations used, the reaction was proportional to protein concentration (1) . Buffer blanks and inactivated cells blanks (immersed in boiling water for 30 min before assay) gave identical results after 2-h incubations, and one or both were included in each assay. Total 5'-deiodinase activity was the result of incubations carried out without any inhibitor. The lower limit of sensitivity of assay C was 10 fmol/h per mg protein. CVs (Billerica, MA). The lower limit of sensitivity of the assay was 1.0 ng/ml, and the interassay CV was 3.0% for a serum with a mean value of 25.5 ng/ml. The cross-reactivity of the anti-PRL antibody with beta subunit ofhuman chorionic gonadotropin (#hCG) and human placental lactogen was below 0.01%. PRL levels in fresh (not incubated with cells) M-199 with either 10% calf serum or 10% THDCS were undetectable.
(?hCG was measured by a specific homologous RIA using a kit from Corning Medical and Scientific (Medfield, MA). The lower limit of sensitivity of the assay was 3.0 mIU/ml. Fresh M-199 (not previously incubated with cells) supplemented either with 10% calf serum or 10%o THDCS had undetectable levels of(fhCG.
Protein was measured by the method ofBradford (21) using reagents from Bio-Rad Laboratories, and bovine y-globulin as standard. DNA was measured by the method of Burton (22) BSA, bovine serum albumin; IOP, iopanoic acid; freeze + thaw, cells frozen at -60'C and thawed three times before assay; pre-incub. medium, cell-free medium preincubated for 3 h with 2 X 106 cells. *T4 5'-deiodination rates were less than the lower limit of sensitivity of the assay, which was 5% of the rate in control wells in these experiments.
shows the effects of altered incubation conditions on the T4 to T3 conversion rate in assay A. Reductions to half the number of cells caused a decrease to 60% of control in the conversion rate, P < 0.05. Cells immersed in boiling water for 30 min had rates < 5% of that of controls, P < 0.001. When 0.1% bovine serum albumin was added to the system, the rate was reduced to 45% of the control rate, P < 0.005, presumably due to a reduction of the free fraction of the substrate. Addition of 50 nM iopanoic acid to the incubation medium reduced the deiodination to 40% of the control level, P < 0.005, and 1 mM 6-n-propylthiouracil (PTU) decreased the conversion rate by 12-15% in three experiments, P not significant.
In two experiments, 48 h after cells were plated, medium was removed and the petri dishes were allowed to dry at 370C. The cells were then frozen at -60'C, then thawed. The freezing and thawing was repeated another two times, after which deiodinase activity was measured by assay A. No change in T4 5'-deiodination was seen when results were compared with control cells (Fig. 1) .
In order to verify that deiodination was occurring in the cells, i.e., that the enzyme was not released into the medium, the following experiment was carried out. 48 h after the cells were plated, medium was changed and cells were preincubated with serum-free M-199 (without DTT or tracer) for 3 h, after which the preincubation medium was removed and saved, and fresh serum-free medium was added. Then 200 ul of M-199 containing DTT and ['251I]T4 was added to dishes containing (a) cells with fresh medium; (b) cell-free medium previously incubated for 3 h with cells; or (c) cell-free fresh medium. Preincubation medium and fresh medium both had undetectable 5'-deiodination rates (Fig. 1) .
The effects of addition of thyroid hormones on the deiodination rate in assay A are shown in Table I . 10-and 50-nm concentrations of nonradioactive T4 caused a progressive fall in fractional 5'-deiodination, with 50% inhibition occurring below 10 nM, although the total T3 production (fractional conversion X [T4]) increased with higher substrate concentrations. No reduction in the fractional conversion was seen in the presence of 100 nM T3.
The effect of increasing DTT concentrations on the deiodination rate in assay A is shown in Table II . Cells incubated with 4 mM DTT generated 50% of the amount of T3 produced by cells in 10 mM DTT. Although 20 mM DTT increased the deiodination rate above the rate at 10 mM DTT, it caused also a major cell loss: at the end of a 3-h incubation, there were 40% fewer cells in the wells incubated with 20 mM DTT than in those incubated with 10 mM, whereas little or no difference in cell number was seen comparing 10 mM DTT and lower concentrations.
In Studies using cells in primary culture. 24 h after the cells were plated, there was marked reduction in the deiodination rate, then a recovery of activity which persisted through the sixth day, and a subsequent decline (Table III) (Table IV) . The cells that had been kept previously in medium with THDCS had a 64.2±11.6% increase in the deiodination rate above those incubated with normal calf serum. Similarly, in assay B, the thyroid hormone-depleted cells showed a twofold increase in the T4 to T3 conversion rate when tracer T4 and T3 were added to the medium at the beginning of the second 48-h incubation (Table IV) . When assay B incubations were done with tracer rT3, the cells kept in a medium with THDCS had an 85.0±5.0% increase above those kept in normal calf serum (data not shown). Lastly, cells were collected and washed, after a 48-h incubation, either with normal calf serum or THDCS, and cell sonicates were assayed in the presence of 1 nM T4 (assay C). The T4 5'-deiodination rate in sonicates of cells incubated in thyroid hormone-depleted medium was 81±14% greater than that in cells incubated with normal serum (Table IV) . The added T4 concentration in assay C, 1 nM, was much greater than that contributed by the T4 content of cells cultured in either type of serum: 125±25 pM from cells in normal calf serum and 26±6 pM from cells in THDCS, as monitored by tracer T4 added to parallel wells. 2 Thus, all three assays showed a near doubling of 5'-deiodination after 48 h deprivation ofthyroid hormone. The increase 2. These concentrations were calculated using wells incubated in parallel to the experimental wells, with the addition of tracer T4. At the end of the culture incubations, cells from these wells were collected, washed, and pelletted as for the experimental cells. The pellets were counted, extracted with ethanol, and chromatographed to verify that the radioactivity was still almost all T4. From the percentage of total [125I1T4 counts found in the pellet and the known amount of nonradioactive T4 in each well, the gravimetric content of T4 in the pellet was calculated, and from that the concentration of T4 in sonicate was calculated. 
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Cells were incubated for 48 h in medium containing 10% calf serum or 10% THDCS. In assays A and C, deiodination was measured after the 48 h, while in assay B deiodinase activity was measured during the 48 h. Results are mean±SD of individual experimental means. Within each experiment, the difference in deiodination rates between cells incubated in the two media was significant, with P < 0.002 by the t test.
was not due to a difference in tracer T4 specific activity, as judged by assay C results, and did not require the presence of DTT, as judged by assay B results. In both assay A and C, when results were expressed per microgram DNA instead of per milligram protein, the magnitude of the differences in activity induced by calf serum and THDCS were similar to those in Table IV (data not shown).
In time-course studies (Fig. 2) , placental cells incubated in a thyroid hormone-depleted medium had significantly higher activity than the controls as early as 12 h after the media were changed, and at all later times. There was little further change in the activity between 36 and 96 h.
To assess whether the rise in 5'-deiodination in the cells incubated with resin-treated serum was due only to thyroid hormone deprivation, two experiments were carried out. In the first, cells were kept in M-199 with 10% calf serum for 48 h, then incubated with medium containing 10% calf serum, 10% 120 - 4- 0.
- with THDCS only. Although the time course of fall of 5'-deiodination induced by all iodothyronines was similar, the fall did not appear to follow a simple exponential decay, and the data were not sufficiently precise for multi-component curve fitting.
Effects of thyroid hormone depletion on medium prolactin and chorionic gonadotropin. Dispersed human chorion-decidual cells produced PRL and ,3hCG and released them into the medium. The secretion of PRL was reasonably constant throughout the 96-h incubation period, whereas secretion of fthCG was greatly diminished in the second 48-h period (Table V) . There was little difference between PRL release in wells containing medium with 10% calf serum and medium with 10% THDCS (Table V) . When results of this experiment and a similar one (not shown) were combined, and data from all time points pooled, PRL secretion by cells in hormone-depleted medium was 12% greater than in control wells. Likewise, in two experiments, one shown in Table V In the present studies we determined the optimal dispersion conditions to obtain viable, dispersed, human, chorion-decidual cells that retain T4 5'-deiodinase activity. The characteristics of deiodination by these intact cells are similar to those described for human chorion-decidual membrane homogenates and microsomes (1) . 50% inhibition of fractional T4 deiodination occurs at a T4 concentration <10 nM, and 1 mM PTU has little effect on the deiodination rate. Response of this placental T4 5'-deiodination reaction to short term (3 h) exposure to DTT, PTU, T3, and iopanoic acid are also very similar to those seen in homogenates or microsomes ofrat anterior pituitary, brain, brown adipose tissue, and placenta (1, 3-6). T4 5'-deiodination in these latter tissues has been termed type II iodothyronine deiodination to distinguish this pathway from another, type I, which is found most abundantly in rat liver and kidney (8) .
The lack of reduction of T4 5'-deiodination in cells submitted to the freezing-thawing process indicates that, at least at supraphysiologic thiol concentrations, integrity of cell architecture does not potentiate deiodinase activity, although in the intact cell system there is no leak of active enzyme into the culture medium. The relatively short persistence, 6 d, of 5'-deiodination activity in human chorion-decidual cells kept in primary culture, could possibly be due to overgrowth ofcells lacking the capacity for 5'-deiodination. The placental membrane used as the source of the cells is composed of several different cell types, which have two different origins: cells in the chorionic membrane proper, of which there are multiple varieties (25) , are of fetal origin, whereas the cells in the adherent decidual layer are of maternal origin. It is not known which of these cell types carry out 5'-deiodination.
Three different assays were used to measure T4 5'-deiodination, because each has strong and weak aspects. Assay C (column assay of cell sonicates) is technically easiest, but has the disadvantage of using a broken cell system. Assays A (shortterm incubation of intact cells) and B (48 h incubation of intact cells) are similar; assay B does not require the addition of the unphysiologic DTT, but is longer and results in lower deiodination rates. Of note is the minimal inhibition of T4 5'-deiodination by 1 mM PTU in all three assays, particularly in assay '.
. im., .W 5 '-deiodination, while repletion caused a fall in the activity. There are two different mechanisms of reduction of fractional T4 deiodination by addition of iodothyronines. In assay A, addition of T4 greatly reduces the tracer specific activity, and, despite low fractional T4 deiodination, the molar rate of T3 production increases with increasing T4 concentrations (cf. Table I ). This merely represents saturation of the enzyme by substrate. In this system, addition of 100 nM T3had no effect.
In contrast, when cells previously kept in 10% THDCS were incubated in the same medium supplemented with T4, T3, or rT3, the consequent marked reduction in T4 5'-deiodination truly reflected decreased enzyme activity, because tracer specific activity was not altered substantially during the deiodinase assay (assay C). Here, additions of T3, as well as of T4 and rT3, to THDCS did have effects, which were namely to prevent the rise in deiodination rate induced by thyroid hormone deprivation and to reverse an increased activity already established. That these effects are really hormonal, or biological in nature, not merely a reflection of enzyme kinetics, is further suggested by their occurrence at physiological T4 concentrations. Although we did not directly measure the free T4 and free T3 concentrations in culture media, dilution of the calf serum in M-199 should keep the free T4 and free T3 concentrations very nearly the same as in whole serum. Thus, the total T4 concentration in M-199 with 10% calf serum, 10.4 nM, corresponds to a physiological free T4 concentration, and restoration of similar amounts of T4 to the hormone-depleted serum abolishes its capacity to induce and maintain raised T4 5'-deiodinase activity. For T3, in contrast, prevention of the rise in enzyme activity requires a 60-nM concentration, >200 times the level in medium containing 10% normal calf serum, 0.26 nM T3. Leonard and Larsen (26) , studying type II T4 5'-deiodination in cultured fetal rat brain cells, found that reaction rates in cells cultured in medium containing iodothyronine-stripped serum was about twofold higher than in cells cultured in the presence of normal serum. Addition of 100 nM T4 or T3 prevented the increase in activity. Similarly, they found that PTU-insensitive rT3 5'-deiodination was increased in the presence of stripped serum, and this increase was partly prevented by 10 or 100 nM T3. They did not test lower concentrations. In our system, T4 and T3 appear to be more potent, in that lower concentrations reversed the effects of stripped serum.
The relative potencies of T4, T3, and rT3, and the small amount of T4 degradation in 48 h of culture (assay B), indicate that the effect ofT4 could not be explained by its transformation to T3 or rT3. Although T3 is a more potent thyroid hormone than T4 in most respects, and although rT3 is not calorigenically active, there are some other systems in which T4 is as potent as T3 (27, 28), and some in which rT3 has effects similar to T4 and T3 (27, 29) . The relative potencies we find for these three iodothyronines are in notably good agreement with the results of Silva and Leonard (30) regarding changes in rat brain and pituitary type II deiodinase after in vivo administration of T4, T3, and rT3.
The mechanism of increased T4 5'-deiodination induced in these cells by thyroid hormone deprivation is not known. An increase in enzyme synthesis, decreased degradation, or activation ofquiescent enzyme are among the possibilities. Leonard et al. (31) showed that hypothyroidism does not increase the synthesis of rat cerebrocortical or pituitary type II deiodinase, but rather causes a marked reduction in the enzyme turnover rate. Ofconsiderable interest is evidence that this effect does not require protein synthesis, and therefore is presumably not initiated at the nuclear T3 receptor (31) . These mechanisms will be amenable to testing in the human placental cell system. However, one potential artifact has been reasonably well excluded by our results: a major change in the quantitative distribution of cell types having much different deiodinase activities. First, the protein and DNA content per dish of cells incubated in each type of serum was similar (data not shown). Second, it seems improbable that an altered cell distribution promoted by thyroid hormone depletion would be corrected within 8 h by hormone repletion, whereas enzyme activity declined in this time period. Last, the amounts of prolactin, produced by decidual cells (32) , and of fhCG, produced by trophoblastic cells (33), were similar for cells incubated in medium containing either type of serum. It is therefore reasonable to assume that each of these cell types comprised a similar fraction of the total cells in both normal and hormone-depleted serum, and that it is unlikely that some cell type devoid of 5'-deiodinase activity which was a major component in medium with normal serum, became a minor component when hormonedepleted serum was used.
The rise of 5'-deiodinase activity induced by thyroid hormone deprivation appears to be slower than in the rat. Leonard et al. (31) found a twofold increase in rat cerebrocortical and pituitary type II 5'-deiodinase activity 6 h after thyroidectomy, although Maeda and Ingbar (7) found an increase in rat pituitary activity only at 24 h after thyroidectomy, not earlier. Inhibition by iodothyronines of human placental T4 5'-deiodination previously raised by hormone depletion was also slower than in rat brain and pituitary. Rat cerebrocortical and pituitary type II 5'-deiodinase activity decreased to euthyroid levels 4 h after a single injection of a supraphysiological dose of T3 to hypothyroid animals (31, 34 Although the physiological role of type II 5'-deiodination in man is not established, this pathway might have an adaptive function, helping to prevent a fall in intracellular, and possible plasma, T3 concentrations in mild-to-moderate hypothyroxinemia (8) . Clinical studies offer some support for this hypothesis. Lum et al. (38) studied euthyroid subjects rendered hypothyroxinemic by exogenous T3, and found that after withdrawal of T3, serum T3 levels declined only 22% below pretreatment values, while T4 concentrations remained >50% below pretreatment levels. This phenomenon was not dependent on thyrotropin secretion, nor was it due to changes in secretory activity of the thyroid gland, as judged by serum thyrotropin measurements and similar changes in T3/T4 ratios in athyreotic patients after T3 withdrawal. Fischer et al. (39) treated a group of thyrotoxic patients with either propylthiouracil or carbimazole to the point of a rise in serum thyrotropin. Serum T3 levels fell to normal in parallel with T4, but no further drop in T3 was seen, despite a continued decline in the T4 to subnormal concentrations, during the time before resumption ofthyrotropin secretion was evident. The discrepancies between T4 and T3 in these studies suggest that there is a mechanism in man that moderates plasma, and probably intracellular, T3 deficiency in states of diminished T4 availability. Type II 5'-deiodination has the appropriate characteristics to play such a role, whereas type I deiodination does not (7) , and the response of the low Km kidney process (9) to hypothyroidism has not been reported.
Animal studies are also suggestive of an adaptive function for type II deiodination. In the rat cerebral cortex, cerebellum, and anterior pituitary, the majority of the intracellular T3 is produced locally by type II 5'-deiodination of T4, as reviewed in reference 8. Silva and Matthews (13) found that in 2-wk-old euthyroid rats, PTU-insensitive T4 5'-deiodination was the predominant in vivo pathway to extrathyroidal T3 production, and all such production was PTU insensitive in hypothyroid pups. Silva et al. (40) have also shown that in hypothyroid adult rats, practically all T3 produced in vivo from low doses ofexogenous T4 was generated via a PTU-insensitive pathway. The 
